In the context of ventricular dysfunction, Galectin-3 levels were negatively correlated with both EDV and ESV in patients with diabetes, emphasizing the potential utility of Galectin-3 as an early biomarker to identify diabetic patients at higher cardiovascular risk despite apparently normal volumetric parameters. The gene discussed is LGALS3; the disease is diabetes mellitus.